Skip to content
HowShorted

RIGEL PHARMACEUTICALS INC short interest in 2026

In 2026, RIGEL PHARMACEUTICALS INC's disclosed short interest ran from 20.39% of shares outstanding on 15 Jan 2026 to 17.09% on 15 Sep 2026, a change of -3.30 percentage points. The year's high was 22.71% on 15 Apr 2026 and its low 16.56% on 31 Jul 2026, averaging 19.52% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.83 days on 15 Sep 2026. Full history: RIGEL PHARMACEUTICALS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for RIGEL PHARMACEUTICALS INC in 2026

2026 in figures

Start of year
20.39% (15 Jan 2026)
End of year
17.09% (15 Sep 2026)
Change
-3.30 pp
High
22.71% (15 Apr 2026)
Low
16.56% (31 Jul 2026)
Average
19.52%
Highest days to cover
15.83 (15 Sep 2026)
SEC filings marked
7

Every report in 2026

RIGEL PHARMACEUTICALS INC short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202620.39%6.72results (8-K)
30 Jan 202620.55%12.12
13 Feb 202620.90%14.25
27 Feb 202620.67%13.00
13 Mar 202620.55%7.0610-K filed, results (8-K)
31 Mar 202620.99%13.26
15 Apr 202622.71%11.26
30 Apr 202621.27%12.09
15 May 202621.33%7.4910-Q filed, results (8-K)
29 May 202621.27%12.02
15 Jun 202618.69%11.18
30 Jun 202617.58%7.18
15 Jul 202617.07%7.87
31 Jul 202616.56%10.55
14 Aug 202617.15%9.7610-Q filed, results (8-K)
31 Aug 202617.03%9.11
15 Sep 202617.09%15.83

See also: RIGEL PHARMACEUTICALS INC's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.